Stanford School of Medicine

Chemical & Systems Biology


Pharmacological inhibition of βIIPKC is cardioprotective in late-stage hypertrophy.

Posted by CSB Department on December 1, 2011

Ferreira JC, Koyanagi T, Palaniyandi SS, Fajardo G, Churchill EN, Budas G, Disatnik MH, Bernstein D, Brum PC, Mochly-Rosen D. (2011) J. Mol. Cell. Cardiol. 51(6):980-7 [PubMed]